EKTAY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 15:57):

Stats
Today's Volume	8 258.00
Average Volume	8 461.00
Market Cap	2.71B
EPS	$0 ( 2024-03-01 )
Next earnings date	( $0 ) 2024-05-23
Last Dividend	$0.117 ( 2023-08-25 )
Next Dividend	$0 ( N/A )
P/E	20.35
ATR14	$0.0200 (0.29%)

Elekta AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Elekta AB (publ) Financials

Annual	2023
Revenue:	$16.87B
Gross Profit:	$6.35B (37.64 %)
EPS:	$2.47

Q3	2024
Revenue:	$4.54B
Gross Profit:	$1.66B (36.65 %)
EPS:	$0.800

Q2	2024
Revenue:	$4.73B
Gross Profit:	$1.70B (35.82 %)
EPS:	$0.900

Q1	2024
Revenue:	$3.83B
Gross Profit:	$1.59B (41.54 %)
EPS:	$0.620

Financial Reports:

No articles found.

Elekta AB (publ) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.118 (N/A)	$0 (N/A)	$0.118 (N/A)	$0 (N/A)	$0.117 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Elekta AB (publ) Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.92 - Stable (1.52%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.305	2013-09-04
Last Dividend	$0.117	2023-08-25
Next Dividend	$0	N/A
Payout Date	2023-09-15
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	$1.985	--
Avg. Dividend % Per Year	0.00%	--
Score	3.83	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.92
Div. Directional Score	8.84	--

Next Divdend (Est)
(2024-10-03)

$0.123 Estimate 7.07 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.83

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
OMVKY	Ex Dividend Knight	2023-06-06	Annually	0.00%
DWAHF	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
TPDKY	Ex Dividend Knight	2023-04-27	Annually	0.00%
JARLF	Ex Dividend Knight	2023-08-17	Semi-Annually	0.00%
BPOSY	Ex Dividend Knight	2023-05-18	Annually	0.00%
QBIEY	Ex Dividend Knight	2023-08-21	Annually	0.00%
FBPA	Ex Dividend Junior	2023-08-18	Semi-Annually	0.00%
UUGRY	Ex Dividend Junior	2023-06-22	Semi-Annually	0.00%
LDSCY	Ex Dividend Junior	2023-08-24	Quarterly	0.00%
CKNQP	Ex Dividend Junior	2023-09-14	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0786	1.500	8.43	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0466	1.200	8.45	10.00	[0 - 0.3]
returnOnEquityTTM	0.141	1.500	9.54	10.00	[0.1 - 1]
payoutRatioTTM	0.640	-1.000	3.60	-3.60	[0 - 1]
currentRatioTTM	1.095	0.800	9.53	7.62	[1 - 3]
quickRatioTTM	0.822	0.800	9.87	7.90	[0.8 - 2.5]
cashRatioTTM	0.181	1.500	-0.104	-0.156	[0.2 - 2]
debtRatioTTM	0.198	-1.500	6.70	-10.00	[0 - 0.6]
interestCoverageTTM	6.24	1.000	8.80	8.80	[3 - 30]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.98	2.00	8.01	10.00	[0 - 20]
debtEquityRatioTTM	0.593	-1.500	7.63	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.377	1.000	7.04	7.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.129	1.000	9.41	9.41	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.516	1.000	8.25	8.25	[0.2 - 2]
assetTurnoverTTM	0.593	0.800	9.38	7.50	[0.5 - 2]
Total Score				12.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.41	1.000	8.04	0	[1 - 100]
returnOnEquityTTM	0.141	2.50	9.70	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.98	2.00	8.67	10.00	[0 - 30]
dividendYielPercentageTTM	0.303	1.500	2.42	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
payoutRatioTTM	0.640	1.500	3.60	-3.60	[0 - 1]
pegRatioTTM	-0.103	1.500	-4.02	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.172	1.000	8.20	0	[0.1 - 0.5]
Total Score				4.92

Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.